The neuron‐specific isoform of glycogen synthase kinase‐3β is required for axon growth
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
J. Neurochem. (2010) 10.1111/j.1471‐4159.2010.06581.x Glycogen synthase kinase‐3 (GSK‐3) has become an important target for the treatment of mood disorders and neurodegenerative disease. It comprises three enzymes, GSK‐3α, β and the neuron‐specific isoform, β2. GSK‐3 regulates axon growth by phosphorylating microtubule‐associated proteins including Tau. A genetic polymorphism that leads to an increase in the ratio of GSK‐3β1 to GSK‐3β2 interacts with Tau haplotypes to modify disease risk in Parkinson’s and Alzheimer’s disease. We have examined the roles of each isoform of GSK‐3 in neurons. Silencing of GSK‐3β2 inhibited retinoic acid‐induced neurite outgrowth in SH‐SY5Y neuroblastoma cells and axon growth in rat cortical neurons. Inhibition of neurite outgrowth was prevented by co‐expression of GSK‐3β2 but not by co‐expression of GSK‐3α or GSK‐3β1. Ectopic expression GSK‐3β2 enhanced the effects of retinoic acid on neurite length and induced neurite formation in the absence of retinoic acid. GSK‐3β2 phosphorylated Tau at a subset of those sites phosphorylated by GSK‐3β1. In addition, Axin, which regulates responses to Wnt signals, associated more readily with GSK‐3β1 than with GSK‐3β2. Our results suggest that GSK‐3 inhibitors that target the Axin‐binding site in GSK‐3 will preserve the beneficial effects of GSK‐3β2 on axon growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GSK3 takes centre stage more than 20 years after its discovery
FRAME, S., & COHEN, P. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590001 · Cited by 1,433
Microtubule assembly, organization and dynamics in axons and dendrites
Conde, C., & Cáceres, A. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2631 · Cited by 1,086
Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
Hanger, D. P., Anderton, B. H., & Noble, W. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.01.003 · Cited by 965
The Roles of APC and Axin Derived from Experimental and Theoretical Analysis of the Wnt Pathway
Lee, E., Salic, A., Krüger, R., Heinrich, R., & Kirschner, M. W. (2003) · PLoS Biology · doi:10.1371/journal.pbio.0000010 · Cited by 708
Tau phosphorylation in neuronal cell function and dysfunction
Johnson, G. V. W., & Stoothoff, W. H. (2004) · Journal of Cell Science · doi:10.1242/jcs.01558 · Cited by 624
Structural basis for recruitment of glycogen synthase kinase 3β to the axin—APC scaffold complex
Dajani, R., Fraser, E., Roe, S. M., Yeo, M., Good, V. M., Thompson, V., Dale, T. C., & Pearl, L. H. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg068 · Cited by 315
GSK3B polymorphisms alter transcription and splicing in Parkinson's disease
Kwok, J. B. J., Hallupp, M., Loy, C. T., Chan, D. K. Y., Woo, J., Mellick, G. D., Buchanan, D. D., Silburn, P. A., Halliday, G. M., & Schofield, P. R. (2005) · Annals of Neurology · doi:10.1002/ana.20691 · Cited by 205
Nemo‐like kinase is involved in NGF‐induced neurite outgrowth via phosphorylating MAP1B and paxillin
Ishitani, T., Ishitani, S., Matsumoto, K., & Itoh, M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06400.x · Cited by 46 · cited 1×
“For example, nerve growth factor induces GSK-3 phosphorylation of MAP-1B to maintain microtubules in a dynamic state, a prerequisite for neurite outgrowth (Goold and Gordon-Weeks 2001; Ishitani et al. 2009).”
Background
Cited by
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Beurel, E., Grieco, S. F., & Jope, R. S. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.016 · Cited by 1,768
GSK3 signalling in neural development
Hur, E.-M., & Zhou, F.-Q. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2870 · Cited by 838
What Are the bona fide GSK3 Substrates?
Sutherland, C. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/505607 · Cited by 345
GSK-3 and tau: a key duet in Alzheimer’s disease
Sayas, C. L., & Ávila, J. (2021) · Cells · doi:10.3390/cells10040721 · Cited by 314
Canonical and noncanonical Wnt signaling in neural stem/progenitor cells
Bengoa-Vergniory, N., & Kypta, R. M. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2028-6 · Cited by 159
Self-citation
Metadata
- Authors
- Castaño, Z., Gordon‐Weeks, P. R., & Kypta, R. M.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2010-03-03
- Volume
- 113
- Issue
- 1
- Pages
- 117-130
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2058369799
- Cited by
- 60
- References
- 8
- FWCI
- 3.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The neuron‐specific isoform of glycogen synthase kinase‐3β is required for axon growth. https://app.cochat.ai/papers/10.1111/j.1471-4159.2010.06581.x
- The paper
- Castaño, Z., Gordon‐Weeks, P. R., & Kypta, R. M. (2010). The neuron‐specific isoform of glycogen synthase kinase‐3β is required for axon growth. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2010.06581.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.